Related references
Note: Only part of the references are listed.A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumors
J. B. Vermorken et al.
ANNALS OF ONCOLOGY (2013)
Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma
Huey-En Tzeng et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Loss of p53 in Enterocytes Generates an Inflammatory Microenvironment Enabling Invasion and Lymph Node Metastasis of Carcinogen-Induced Colorectal Tumors
Sarah Schwitalla et al.
CANCER CELL (2013)
Microwave-assisted synthesis of arene ruthenium(II) complexes that induce S-phase arrest in cancer cells by DNA damage-mediated p53 phosphorylation
Qiong Wu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
18F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma
Chang-Bae Kong et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
c-Myc phosphorylation by PKCζ represses prostate tumorigenesis
Ji Young Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Transforming Growth Factor β1 Signal is Crucial for Dedifferentiation of Cancer Cells to Cancer Stem Cells in Osteosarcoma
Haixia Zhang et al.
STEM CELLS (2013)
Synergistic Interaction of Rnf8 and p53 in the Protection against Genomic Instability and Tumorigenesis
Marie-Jo Halaby et al.
PLOS GENETICS (2013)
Signal Amplification of Graphene Oxide Combining with Restriction Endonuclease for Site-Specific Determination of DNA Methylation and Assay of Methyltransferase Activity
Wen Li et al.
ANALYTICAL CHEMISTRY (2012)
Imidazo [4,5f][1,10] phenanthroline derivatives as inhibitor of c-myc gene expression in A549 cells via NF-kappa B pathway
Dong-dong Sun et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Charles Y. Lin et al.
CELL (2012)
Arene-RuII Complexes of Curcumin Exert Antitumor Activity via Proteasome Inhibition and Apoptosis Induction
Laura Bonfili et al.
CHEMMEDCHEM (2012)
DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells
Naoe Taira et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Ruthenium-Arene Complexes of Curcumin: X-Ray and Density Functional Theory Structure, Synthesis, and Spectroscopic Characterization, in Vitro Antitumor Activity, and DNA Docking Studies of (p-Cymene)Ru(curcuminato)chloro
Francesco Caruso et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers
Dinis Pedro Calado et al.
NATURE IMMUNOLOGY (2012)
Metal Complexes as DNA Intercalators
Hong-Ke Liu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Study of the incorporation and release of the non-conventional half-sandwich ruthenium(II) metallodrug RAPTA-C on a robust MOF
Elsa Quartapelle Procopio et al.
CHEMICAL COMMUNICATIONS (2011)
DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents
Annamaria Biroccio et al.
CLINICAL CANCER RESEARCH (2011)
C-MYC Alterations and Association With Patient Outcome in Early-Stage HER2-Positive Breast Cancer From the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Interactions of arene-Ru(II)-chloroquine complexes of known antimalarial and antitumor activity with human serum albumin (HSA) and transferrin
Alberto Martinez et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2011)
Inhibition of Cell Proliferation by Quindoline Derivative (SYUIQ-05) through its Preferential Interaction with c-myc Promoter G-Quadruplex
Tian-Miao Ou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Nanoscaled carborane ruthenium(II)-arene complex inducing lung cancer cells apoptosis
Gen Zhang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2011)
The c-MYC NHE III1: Function and Regulation
Veronica Gonzalez et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
An ARF-Independent c-MYC-Activated Tumor Suppression Pathway Mediated by Ribosomal Protein-Mdm2 Interaction
Everardo Macias et al.
CANCER CELL (2010)
In vitro Ruthenation of Human Breast Cancer Suppressor Gene 1 (BRCA1) by the Antimetastasis Compound RAPTA-C and Its Analogue CarboRAPTA-C
Adisorn Ratanaphan et al.
CHEMISTRY & BIODIVERSITY (2010)
Arene ruthenium complexes as anticancer agents
Georg Suess-Fink
DALTON TRANSACTIONS (2010)
Arene-Ru(II)-chloroquine complexes interact with DNA, induce apoptosis on human lymphoid cell lines and display low toxicity to normal mammalian cells
Alberto Martinez et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Disabling c-Myc in Childhood Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor Cells by the Potent G-Quadruplex Interactive Agent S2T1-6OTD
Tarek Shalaby et al.
MOLECULAR CANCER THERAPEUTICS (2010)
c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis
T. Shimizu et al.
ONCOGENE (2010)
Photocontrolled nucleobase binding to an organometallic RuII arene complex
Soledad Betanzos-Lara et al.
CHEMICAL COMMUNICATIONS (2009)
Enhancement Effect of Adenovirus-Mediated Antisense c-myc and Caffeine on the Cytotoxicity of Cisplatin in Osteosarcoma Cell Lines
Xian-kuan Xie et al.
CHEMOTHERAPY (2009)
Functionalised η6-arene ruthenium complexes
Bruno Therrien
COORDINATION CHEMISTRY REVIEWS (2009)
Selective cytotoxic Ru(II) arene Cp* complex salts [R-PhRuCp*]+X- for X = BF4-, PF6-, and BPh4-
Bradley T. Loughrey et al.
INORGANIC CHEMISTRY (2008)
The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways
Soumya Chatterjee et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2008)
Modelling Myc inhibition as a cancer therapy
Laura Soucek et al.
NATURE (2008)
Non-transcriptional control of DNA replication by c-Myc
David Dominguez-Sola et al.
NATURE (2007)
Recombinant antisense c-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin
XK Xie et al.
CANCER INVESTIGATION (2006)
Conformation of DNA modified by monofunctional Ru(II) arene complexes: Recognition by DNA binding proteins and repair. Relationship to cytotoxicity
O Novakova et al.
CHEMISTRY & BIOLOGY (2005)
Progress toward the development of agents to modulate the cell cycle
PL Toogood
CURRENT OPINION IN CHEMICAL BIOLOGY (2002)
Phytochemicals as Cell Cycle Modulators A Less Toxic Approach in Halting Human Cancers
Rana P. Singh et al.
CELL CYCLE (2002)
Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis
S Fulda et al.
ONCOGENE (2001)
Share Paper
